Format
Sort by
Items per page

Send to

Choose Destination

Best matches for type 1 diabetes hepatitis c:

Interferon therapy in hepatitis C leading to chronic type 1 diabetes. Zornitzki T et al. World J Gastroenterol. (2015)

Hepatitis C virus and type 1 diabetes. Fallahi P et al. Clin Ter. (2013)

Hepatitis C virus infection and type 2 diabetes. Fallahi P et al. Clin Ter. (2013)

Search results

Items: 1 to 20 of 146

1.

[Type 1 diabetes millitus following short-term recombinant interferon therapy in patient with chronic hepatitis C].

Shi XY, Zhang K, Zhang L.

Zhonghua Nei Ke Za Zhi. 2018 Jul 1;57(7):524-525. doi: 10.3760/cma.j.issn.0578-1426.2018.07.012. Chinese. No abstract available.

PMID:
29996274
2.

Fulminant type 1 diabetes caused by peginterferon α-2a therapy in hepatitis C.

Zheng Y, Wang Z, Xie Z, Dai R, Zhou Z.

J Diabetes. 2018 May;10(5):419-420. doi: 10.1111/1753-0407.12636. Epub 2018 Feb 5. No abstract available.

PMID:
29265717
3.

Multiple Endocrine and Neoplastic Diseases After Unsuccessful Treatment of Hepatitis C With Interferon and Ribavirin.

Attarian S, Sharma J, Kaubisch A, Zonszein J, Haigentz M Jr.

Am J Med Sci. 2017 Jul;354(1):66. doi: 10.1016/j.amjms.2016.10.001. Epub 2016 Oct 18. No abstract available.

PMID:
28755736
4.

Chronic hepatitis B virus infection status is more prevalent in patients with type 2 diabetes.

Lu J, Hou X, Tu H, Tang Z, Xiang Y, Bao Y, Gu J, Jia W.

J Diabetes Investig. 2017 Jul;8(4):619-625. doi: 10.1111/jdi.12609. Epub 2017 Mar 13.

5.

Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus.

Elkabbany ZA, Elbarbary NS, Ismail EA, Mohamed NA, Ragab D, Abdel Alem S, Ezzat YM, Maurice SS, Hashem NU.

J Diabetes Complications. 2017 Jan;31(1):186-194. doi: 10.1016/j.jdiacomp.2016.09.009. Epub 2016 Sep 26.

PMID:
27742550
6.

Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.

Gill G, Bajwa H, Strouhal P, Buch HN.

J Med Case Rep. 2016 Sep 15;10(1):253. doi: 10.1186/s13256-016-1028-y.

7.

Hepatitis C virus infection among patients with diabetes mellitus in Dammam, Saudi Arabia.

Ba-Essa EM, Mobarak EI, Al-Daghri NM.

BMC Health Serv Res. 2016 Jul 27;16:313. doi: 10.1186/s12913-016-1578-0.

8.

The correlation analysis of primary liver cancer with Type 2 diabetes.

Su Q, Sun F, Li J, Zhang H, Wang M, Zhou H, Qiao L.

Indian J Cancer. 2015 Dec;52 Suppl 3:E148-52. doi: 10.4103/0019-509X.186557.

9.

Pancreas transplantation in unconventional recipients.

Lo DJ, Sayed BA, Turgeon NA.

Curr Opin Organ Transplant. 2016 Aug;21(4):393-8. doi: 10.1097/MOT.0000000000000334.

PMID:
27328037
10.

Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes.

Pham MN, von Herrath MG, Vela JL.

Front Immunol. 2016 Jan 11;6:651. doi: 10.3389/fimmu.2015.00651. eCollection 2015. Review.

11.

The Role of Human Herpesvirus 8 in Diabetes Mellitus Type 2: State of the Art and a Medical Hypothesis.

Pompei R.

Adv Exp Med Biol. 2016;901:37-45. doi: 10.1007/5584_2015_5014. Review.

PMID:
26542602
12.

Diabetes and Hepatitis C: A Two-Way Association.

Hammerstad SS, Grock SF, Lee HJ, Hasham A, Sundaram N, Tomer Y.

Front Endocrinol (Lausanne). 2015 Sep 14;6:134. doi: 10.3389/fendo.2015.00134. eCollection 2015. Review.

13.

T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection.

McKinney EF, Lee JC, Jayne DR, Lyons PA, Smith KG.

Nature. 2015 Jul 30;523(7562):612-6. doi: 10.1038/nature14468. Epub 2015 Jun 29.

14.

Hepatic arteriolosclerosis: a small-vessel complication of diabetes and hypertension.

Balakrishnan M, Garcia-Tsao G, Deng Y, Ciarleglio M, Jain D.

Am J Surg Pathol. 2015 Jul;39(7):1000-9. doi: 10.1097/PAS.0000000000000419.

15.

Interferon therapy in hepatitis C leading to chronic type 1 diabetes.

Zornitzki T, Malnick S, Lysyy L, Knobler H.

World J Gastroenterol. 2015 Jan 7;21(1):233-9. doi: 10.3748/wjg.v21.i1.233. Review.

16.

Assessment of evidence for positive association and seroprevalence of hepatitis B and C in diabetic patients in a developing country.

Korkmaz H, Kesli R, Onder Pamuk B, Ipekci SH, Terzi Y, Kebapcilar L.

J Investig Med. 2015 Feb;63(2):251-7. doi: 10.1097/JIM.0000000000000126.

PMID:
25415060
17.

Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

Antonelli A, Ferrari SM, Giuggioli D, Di Domenicantonio A, Ruffilli I, Corrado A, Fabiani S, Marchi S, Ferri C, Ferrannini E, Fallahi P.

World J Diabetes. 2014 Oct 15;5(5):586-600. doi: 10.4239/wjd.v5.i5.586. Review.

18.

Not so sweet: autoimmune diabetes mellitus on triple therapy for chronic hepatitis C infection.

Blanchard E, Vickers CR, Samaras K.

Diabet Med. 2015 Feb;32(2):e1-3. doi: 10.1111/dme.12585.

PMID:
25204264
19.

Acute kidney injury in a diabetic haemophiliac: one step at a time.

Althaf MM, Hussein MH, Abdelsalam MS, Amer SM.

BMJ Case Rep. 2014 May 8;2014. pii: bcr2014203967. doi: 10.1136/bcr-2014-203967.

20.

Hepatitis C virus infection in Egyptian children with type 1 diabetes mellitus: A single center study.

Farghaly HS, Metwalley KA, El-Hafeez HA.

Indian J Endocrinol Metab. 2014 Mar;18(2):197-201. doi: 10.4103/2230-8210.129111.

Supplemental Content

Loading ...
Support Center